19:50 EDT Quoin Pharmaceuticals (QNRX) Ltd – ADR trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNRX:
- Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested
- Quoin announces additional data from Pediatric Netherton Syndrome study
- Quoin files U.S. patent application for novel topical formulations
- Buy Rating for Quoin Pharmaceuticals: Promising Phase 3 Trials and Strong Financial Position
- Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year
